GENESEARCH BREAST LYMPH NODE (BLN) ASSAY

FDA Premarket Approval P060017 S004

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Extension of shelf-life of plasmid dna raw material used in the manufacture of the external positive and external negative controls of the device.

DeviceGENESEARCH BREAST LYMPH NODE (BLN) ASSAY
Generic NameRt-pcr Multigene Expression Test, Sentinel Lymph Node, Cancer Metastasis Detection
ApplicantJANSSEN DIAGNOSTICS
Date Received2009-11-19
Decision Date2009-12-17
PMAP060017
SupplementS004
Product CodeOCB 
Advisory CommitteePathology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address JANSSEN DIAGNOSTICS 700 Us Highway Rte 202 South raritan, NJ 08869

Supplemental Filings

Supplement NumberDateSupplement Type
P060017Original Filing
S004 2009-11-19 30-day Notice
S003 2009-03-02 Normal 180 Day Track No User Fee
S002
S001 2007-08-15 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.